Sagility India Gets Sebi Nod IPO


The IPO, with a face value of Rs 10 per equity share, is entirely an offer for sale of up to 984.46 million equity shares by Sagility B.V, the Promoter Selling Shareholder.


FinTech BizNews Service 

Mumbai, 15 October, 2024: Sagility India Limited, one of the largest technology-enabled, pure-play healthcare focused solutions and services provider to Payers, and Providers, has received final observation from the capital markets regulator, Securities and Exchange Board of India (SEBI), to raise funds through an initial public offering (IPO). The Company had filed its IPO papers with Sebi on June 28, 2024. The IPO, with a face value of Rs 10 per equity share, is entirely an offer for sale of up to 984.46 million equity shares by Sagility B.V, the Promoter Selling Shareholder. 

The offer includes a reservation for subscription by eligible employees. Established in 2021, the Bengaluru based company provides technology-driven services to both Payers and Providers, covering core benefits administration and clinical services. These include claims management, payment integrity, clinical management, and more. For Providers, it offers revenue cycle management services to help with billing and treatment cost claims from Payers. It also extends some of its Payer services to pharmacy benefit managers (PBMs), who manage prescription drugs for insured individuals under health plans. 

Health payers are entities that pay for or reimburse healthcare services for insured members through health insurance plans. Healthcare providers are individuals or healthcare facilities that are licensed to deliver care services or aid in care delivery such as doctors, clinics, hospitals, labs, durable medical equipment providers besides others ICICI Securities Limited, IIFL Securities Limited, Jefferies India Private Limited, J.P. Morgan India Private Limited are the book-running lead managers, and Link Intime India Private Limited is the registrar of the issue.

Cookie Consent

Our website uses cookies to provide your browsing experience and relavent informations.Before continuing to use our website, you agree & accept of our Cookie Policy & Privacy